Compared to Estimates, ResMed (RMD) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare ...

ResMed tops quarterly profit estimates on strong demand for sleep apnea devices

ResMed beat Wall Street estimates for quarterly profit on Wednesday due to strong demand for its sleep apnea devices, sending shares 9% higher in extended trading.

ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Investors Should Buy ResMed (RMD) Stock Now

Investors are optimistic about ResMed (RMD) led by the strong uptake of the myAir app with Air 11 systems.

The 7 Best Stocks to Buy With Your Required Minimum Distribution (RMD)

Once you reach the age of 73, there's no getting around Required Minimum Distributions (RMDs). Yet while there's no getting around making this compulsory withdrawal from your 401(k) or IRA, conside...

ResMed (RMD) Debuts the Smallest Full-Face CPAP Mask AirFit F40

ResMed's (RMD) new AirFit F40 mask combines the ease and comfort of an ultra-compact, full-face mask with the effectiveness of a traditional over-the-nose, full-face mask.

Why Is ResMed (RMD) Down 1.7% Since Last Earnings Report?

ResMed (RMD) reported earnings 30 days ago. What's next for the stock?

ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)

ResMed's (RMD) new AirCurve11 series incorporates MyAir and AirView digital health apps to provide maximum comfort and support during therapy.

ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 Device

ResMed's (RMD) new AirCurve11 series incorporates myAir and AirView digital health apps to provide maximum comfort and support during therapy.

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Three-Stock Lunch: SoFi, Warner Bros. Discovery and ResMed

Boris Schlossberg, BK Asset Management, joins 'Power Lunch' to discuss SoFi, Warner Bros. Discovery and ResMed.

Here's Why ResMed (RMD) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

ResMed (RMD) Q2 Earnings Beat Estimates, Margins Expand

ResMed's (RMD) Q2 results reflect cost discipline to support an acceleration in profitability.

Why ResMed Stock Is Jumping Today

ResMed topped consensus Wall Street revenue and earnings estimates with its fiscal Q2 results. The company delivered double-digit-percentage growth across all of its products and services.

ResMed Inc. (RMD) Q2 2024 Earnings Call Transcript

ResMed Inc. (RMD) Q2 2024 Earnings Call Transcript


Related Companies

Track Institutional and Insider Activities on RMD

Follow RESMED INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RMD shares.

Notify only if

Insider Trading

Get notified when an Resmed Inc insider buys or sells RMD shares.

Notify only if

News

Receive news related to RESMED INC

Track Activities on RMD